Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

188 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Recruiting

Luspatercept + Darbepoetin in MDS

NCT07096297

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
  • Harold C. Simmons Comprehensive Cancer Center of UT Southwestern Dallas, Texas, United States
View Trial Details
Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424

Conditions
AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies

NCT07347171

Conditions
AML, AML (Acute Myelogenous Leukemia), Anemia, +13 more
Locations
  • The First Affiliated Hospital of Nanchang University Nanchang, China
  • The Haematology Hospital of the Chinese Academy of Medical Sciences Tianjin, China
  • Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, China
View Trial Details

Related conditions